McDermott Advises Brenus Pharma on Its Series A Fundraising
September 21, 2024
September 21, 2024
CHICAGO, Illinois, Sept. 21 -- McDermott Will and Emery, a law firm, issued the following news release:
McDermott Will & Emery has advised Brenus Pharma, a biotech company specializing in the development of cancer vaccines, on its Euros22 million Series A fundraising.
This Series A round, led by a group of French investors in association with Belgian investment funds, will be used to finance a first Phase I/IIA clinical trial for the first candidate, STC-1010 in met . . .
McDermott Will & Emery has advised Brenus Pharma, a biotech company specializing in the development of cancer vaccines, on its Euros22 million Series A fundraising.
This Series A round, led by a group of French investors in association with Belgian investment funds, will be used to finance a first Phase I/IIA clinical trial for the first candidate, STC-1010 in met . . .